
Abiomed ABMD
Quarterly report 2022-Q3
added 11-03-2022
Abiomed Accounts Payables 2011-2026 | ABMD
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Annual Accounts Payables Abiomed
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 34.8 M | 32.8 M | 32.2 M | 23.6 M | 20.6 M | 9.38 M | 10.4 M | 7.75 M | 7.7 M | 6.91 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 34.8 M | 6.91 M | 18.6 M |
Quarterly Accounts Payables Abiomed
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 35.1 M | - | 35.3 M | 32.1 M | 27.6 M | 29.8 M | 34.8 M | 23.6 M | 21.7 M | 27.7 M | 32.8 M | 31.6 M | 31.7 M | 29.7 M | 32.2 M | 26.2 M | 21.9 M | 25.7 M | 23.6 M | 22 M | 16.7 M | 12.8 M | 20.6 M | 14.6 M | 14.1 M | 8.37 M | 9.38 M | 8.84 M | 8.79 M | 8.62 M | 10.4 M | 8.25 M | 7.62 M | 6.76 M | 7.75 M | 6.07 M | 6.18 M | 6.27 M | 7.7 M | 6.31 M | 5.21 M | 6.29 M | 6.91 M | 5.21 M | 4.46 M | 4.96 M | 6.28 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 35.3 M | 4.46 M | 17 M |
Accounts Payables of other stocks in the Medical devices industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
2.76 M | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
352 M | $ 12.07 | 0.33 % | $ 1.63 B | ||
|
Allied Healthcare Products
AHPI
|
1.21 M | - | 3.58 % | $ 2.21 M | ||
|
EDAP TMS S.A.
EDAP
|
5.71 M | $ 3.45 | 1.77 % | $ 129 M | ||
|
Apollo Endosurgery
APEN
|
7.42 M | - | - | $ 475 M | ||
|
Avinger
AVGR
|
777 K | - | -20.74 % | $ 369 K | ||
|
Align Technology
ALGN
|
109 M | $ 171.87 | 0.74 % | $ 12.9 B | ||
|
AxoGen
AXGN
|
2.89 M | $ 32.64 | -5.23 % | $ 1.5 B | ||
|
Axonics Modulation Technologies
AXNX
|
9.07 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
4.79 M | - | 1.37 % | $ 20.5 M | ||
|
Butterfly Network
BFLY
|
4.25 M | $ 4.13 | 0.49 % | $ 874 M | ||
|
BIOLASE
BIOL
|
6.06 M | - | -13.19 % | $ 166 K | ||
|
Bruker Corporation
BRKR
|
234 M | $ 36.74 | -0.05 % | $ 5.47 K | ||
|
Boston Scientific Corporation
BSX
|
1.14 B | $ 62.59 | -0.37 % | $ 92.7 B | ||
|
Alphatec Holdings
ATEC
|
40.9 M | $ 10.97 | 1.29 % | $ 1.65 B | ||
|
CONMED Corporation
CNMD
|
93.6 M | - | - | $ 1.06 B | ||
|
Conformis
CFMS
|
4.16 M | - | - | $ 16.4 M | ||
|
ClearPoint Neuro
CLPT
|
1.26 M | $ 9.38 | 0.11 % | $ 266 M | ||
|
Cardiovascular Systems
CSII
|
14.4 M | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
2.87 M | $ 0.59 | 1.2 % | $ 36.7 M | ||
|
Cutera
CUTR
|
19.8 M | - | -10.19 % | $ 1.99 M | ||
|
Delcath Systems
DCTH
|
2.66 M | $ 9.7 | 0.73 % | $ 347 M | ||
|
Dynatronics Corporation
DYNT
|
3.4 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
6.5 M | - | - | $ 10.2 M | ||
|
Edwards Lifesciences Corporation
EW
|
228 M | $ 81.19 | 0.17 % | $ 47.5 B | ||
|
Second Sight Medical Products
EYES
|
1.03 M | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
2.67 M | $ 23.61 | 1.37 % | $ 200 M | ||
|
FONAR Corporation
FONR
|
1.55 M | $ 18.6 | 0.05 % | $ 122 M | ||
|
Globus Medical
GMED
|
98.9 M | $ 88.6 | 0.77 % | $ 12 B | ||
|
Helius Medical Technologies
HSDT
|
531 K | $ 1.9 | 2.15 % | $ 1.15 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
82.5 M | $ 9.31 | -2.31 % | $ 717 M | ||
|
Inogen
INGN
|
20.3 M | $ 6.36 | 2.42 % | $ 169 M | ||
|
Inspire Medical Systems
INSP
|
36.6 M | $ 54.14 | -1.55 % | $ 1.59 B | ||
|
IRIDEX Corporation
IRIX
|
5.38 M | $ 1.0 | 1.66 % | $ 16.9 M | ||
|
IRadimed Corporation
IRMD
|
1.82 M | $ 95.66 | -0.59 % | $ 1.22 B | ||
|
Integer Holdings Corporation
ITGR
|
113 M | $ 85.63 | -1.4 % | $ 2.97 B | ||
|
Invacare Corporation
IVC
|
105 M | - | - | $ 24.7 M | ||
|
GBS
GBS
|
1.47 M | - | -0.57 % | $ 7.12 M |